Rosetta Biosoftware Licenses the Rosetta Resolver Expression Data Analysis System to University of Nebraska-Lincoln.SEATTLE -- Rosetta Biosoftware announced today that University of Nebraska-Lincoln (UNL UNL Unlisted UNL University of Nebraska-Lincoln UNL Universidade Nova de Lisboa (Portugal) UNL Universidad Nacional del Litoral (Argentina) UNL University of North London UNL Upper Normal Limit ) licensed the Rosetta Resolver(R) system to study gene regulation networks at the UNL Center for Biotechnology. The Resolver system supports high-throughput gene expression studies by providing a framework that enables collaboration across entire organizations and integration with existing bioinformatics tools and resources. "We are excited that the Rosetta Resolver system will be used to support the application of systems biology Systems biology, a field of study in the biosciences, focuses on the systematic study of complex interactions in biological systems. Particularly from 2000 onwards, the term is used widely in the biosciences, and in a variety of contexts. towards agricultural studies at the University of Nebraska," said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware. "The Resolver system is a scalable solution designed to support collaboration within and between organizations." "For high-throughput plant gene expression and regulation studies, we need a highly efficient and effective workflow," said Professor Steve Ladunga at the University of Nebraska-Lincoln. "As an important part of this workflow, the Rosetta Resolver system will provide a means for sophisticated communication between several computational and experimental biologists collaborating on data-intensive projects. The Resolver system will empower us to focus on innovative research and allows us to integrate our own software development for the study of gene regulatory networks in Arabidopsis and crops as well as the chromatin chromatin: see chromosome. remodeling remodeling /re·mod·el·ing/ (re-mod´el-ing) reorganization or renovation of an old structure. bone remodeling events that influence gene expression." The Rosetta Resolver system is developed and supported by Rosetta Biosoftware, and is distributed exclusively by Agilent Technologies This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. . About University of Nebraska-Lincoln The role of the University of Nebraska-Lincoln, www.unl.edu, as the primary intellectual, cultural and economic development resource for the state of Nebraska is fulfilled through the three missions of the university: teaching, research, and service. UNL pursues its missions through the Colleges of Architecture, Arts and Sciences, Business Administration, Engineering and Technology, Hixson-Lied College of Fine and Performing Arts The Hixson-Lied College of Fine and Performing Arts is the fine and performing arts college at the University of Nebraska–Lincoln. The college, initially known as the College of Fine and Performing Arts, was created on July 1, 1993. , Education and Human Sciences, Journalism and Mass Communications, Law, the university-wide Graduate Studies, and the Institute of Agriculture and Natural Resources which includes the College of Agricultural Sciences and Natural Resources, the Agricultural Research Division, the Cooperative Extension Division, and the Conservation and Survey Division. UNL Center for Biotechnology promotes research on all aspects of molecular life sciences research, leading to improvements in agriculture, health care and the environment. The center is supported by the Nebraska Research Initiative funds allocated through the Center for Biotechnology and by funds from the National Science Foundation (EPSCoR Infrastructure grant). For more information about the UNL Center for Biotechnology, visit www.biotech.unl.edu. About the Rosetta Resolver System The Rosetta Resolver system is a high-capacity data storage, retrieval, and analysis solution for gene expression data. The system is ideal for life science research organizations that need to assess compound specificity or toxicity, identify new genes or therapeutic targets or compare and analyze large databases of expression profiles. The Rosetta Resolver system combines flexibility and ease of use with high-performance algorithms to produce a comprehensive solution for rapid analysis of gene expression data. The Rosetta Resolver system can accept and analyze data from a wide variety of expression profiling formats, including Agilent DNA microarrays, and applies Rosetta Biosoftware's proprietary error models to yield quality statistics for every gene expression measurement within the system. These statistics are automatically leveraged by Rosetta Resolver system analysis tools for optimal results. Life science research organizations that have licensed the Rosetta Resolver system include many of the top pharmaceutical companies in the world, such as Aventis Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline and Merck & Co., Inc., as well as premier academic institutions such as the Harvard University Center for Genomics Research and the California Institute of Technology California Institute of Technology, at Pasadena, Calif.; originally for men, became coeducational in 1970; founded 1891 as Throop Polytechnic Institute; called Throop College of Technology, 1913–20. . Additional information about the Rosetta Resolver system can be found on the Rosetta Biosoftware Web site at www.rosettabio.com. About Rosetta Biosoftware Rosetta Biosoftware is a leading provider of informatics solutions for life science research. Its comprehensive software solutions, including the Rosetta Resolver and Elucidator systems, empower life scientists with advanced, scalable, and easy-to-use analysis platforms that accelerate discovery research. Rosetta Biosoftware is a business unit of Rosetta Inpharmatics LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Merck & Co., Inc. (NYSE NYSE See: New York Stock Exchange :MRK MRK Merck & Company (stock symbol) MRK Mayer-Rokitansky-Kuster (anomaly) MRK Manual Remote Keying ). More information about Rosetta Biosoftware is available at www.rosettabio.com. Forward-Looking Statements This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. These statements involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential, or financial performance. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Neither Rosetta Inpharmatics nor Merck & Co., Inc. undertakes any obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect the business of Merck & Co., Inc. including, among others, the extent to which Rosetta Inpharmatics' technology platform can be used in drug discovery programs, uncertainty of market acceptance of Rosetta Inpharmatics' technologies, ability to compete against existing technologies, and those mentioned in the cautionary statements in Item 1 of Merck's Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended Dec. 31, 2005, and in its periodic reports on Form 10-Q Form 10-Q See 10-Q. and Form 8-K Form 8-K The form required by the SEC when a publicly held company incurs any event that might affect its financial situation or the share value of its stock. Form 8-K See 8-K. (if any) which are incorporated by reference. Rosetta Resolver and Elucidator are U.S. registered trademarks of Rosetta Inpharmatics LLC. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion